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Objectives: The detection of dyskinesias-reduced-self-awareness (DRSA), in
Parkinson’s disease (PD), was previously associated to executive and metacognitive
deficits mainly due to dopaminergic overstimulation of mesocorticolimbic circuits.
Response-inhibition dysfunction is often observed in PD. Apart from being engaged
in response-inhibition tasks, the anterior cingulate cortex (ACC), is part of a functional
system based on self-awareness and engaged across cognitive, affective and
behavioural contexts. The purpose of the study was to examine the relationship between
response-inhibition disabilities and DRSA using whole-brain event-related functional
magnetic resonance imaging (fMRI), over the course of a specific executive task.
Methods: Twenty-seven cognitively preserved idiopathic PD patients – presenting
motor fluctuations and dyskinesias – were studied. They underwent a neurological
and neuropsychological evaluation. The presence of DRSA was assessed using the
Dyskinesias Subtracted-Index (DS-I). Cingulate functionality was evaluated with fMRI,
while patients performed an ACC-sensitive GO-NoGO task. Association between blood
oxygenation level dependent response over the whole-brain during the response-
inhibition task and DS-I scores was investigated by regression analysis.
Results: The presence of DRSA was associated with reduced functional recruitment in
the bilateral ACC, bilateral anterior insular cortex and right dorsolateral prefrontal cortex
(pFWE<0.05). Moreover, DS-I scores significantly correlated with percent errors on the
NoGO condition (r = 0.491, pFWE = 0.009).
Discussion: These preliminary findings add evidence to the relevant role of executive
dysfunctions in DRSA pathogenesis beyond the effects of chronic dopaminergic
treatment, with a key leading role played by ACC as part of a functionally impaired
response-inhibition network. Imaging biomarkers for DRSA are important to be studied,
especially when the neuropsychological assessment seems to be normal.
Keywords: Parkinson’s Disease, dyskinesias, self-awareness, response-inhibition, fMRI
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INTRODUCTION
Dyskinesias are disabling motor complications subsequent
to prolonged use of dopaminergic agents in Parkinson’s
disease (PD). In particular, levodopa-induced dyskinesia (LID),
commonly occurs after long duration of treatment, primarily in
the “on-state” medication, negating to some extent its beneficial
effects (Vitale et al., 2001; Jenkinson et al., 2009; Amanzio et al.,
2010; Sitek et al., 2011).
PD patients may be partially or even completely unaware
of the presence of involuntary movements [the so-called
dyskinesias-reduced-self-awareness (DRSA)]. PD patients with
DRSA may therefore not comply with their pharmacological
treatment or take part in potentially dangerous activities
(Jenkinson et al., 2009). Importantly, DRSA is a clinical
phenomenon that can provide untruthful suggestions about the
progression of the disease, modify treatment adherence, adversely
affect patients quality of life as well as impact the burden of
caregivers (Jenkinson et al., 2009).
DRSA has previously been associated with executive
dysfunctions due to a dopaminergic overstimulation of
mesocorticolimbic circuits (Vitale et al., 2001; Leritz et al.,
2004; Amanzio et al., 2010). Indeed, an action monitoring
dysfunction, related to the medial prefrontal – ventral striatal
circuit including the anterior cingulate cortex (ACC), has been
considered to be associated with DRSA, using neuropsychological
paradigms (Amanzio et al., 2010, 2014). According to our
hypothesis regarding the association between DRSA and
executive dysfunction (Amanzio et al., 2010, 2014; Palermo et al.,
2017), DRSA can arise when the comparator mechanism for
“attentive-performance-monitoring” is damaged. In this case, PD
patients may not be able to identify their motor symptoms, and
dyskinesias do not achieve conscious awareness (Blakemore et al.,
2001; Jenkinson et al., 2009). We have therefore demonstrated
the harmful role of dopaminergic pharmacological replacement
treatment on the prefrontal-subcortical loops producing DRSA,
which is linked to specific executive-metacognitive disabilities
in terms of global monitoring, monitoring resolution, control
sensitivity (Leritz et al., 2004; Amanzio et al., 2010), and
the affective component of Theory of Mind (Palermo et al.,
2017).
For what is our knowledge, only the study by Maier
et al. (2016) analysed neural correlates of impaired self-
awareness of motor symptoms in PD. The authors examined
this phenomenon in a cohort of twenty-two PD using data from
18F-fluorodeoxyglucose positron emission tomography (Maier
et al., 2016), discovering that impaired self-awareness of motor
symptoms had its neural substrates in bilateral frontal regions
such as the right precentral gyrus, the right superior frontal gyrus,
the left inferior frontal gyrus and the medial frontal gyrus (Maier
et al., 2016).
Regarding the role of medial prefrontal cortex in impaired
self-awareness (Amodio and Frith, 2006), it has been previously
demonstrated that a reduced functional recruitment of the
MPFC – especially at the level of ACC – may be considered one
of the relevant neurobiological substrates of unawareness in early
Alzheimer’s disease (Amanzio et al., 2011; Spalletta et al., 2014b),
acquired brain injury (Palermo et al., 2014), bipolar disorder
(Palermo et al., 2015), and schizophrenia (Orfei et al.,
2010; Spalletta et al., 2014a). These results seem to suggest
that unawareness of illness in pathologies with different
aetiologies may exhibit overlapping symptoms in the context
of common patterns of hypofunctionality (i.e., similar neural
dysfunction) (Palermo et al., 2014, 2015). Moreover, we have
also demonstrated how unawareness is related to the ability
to shift and inhibit a response and to action-monitoring
(Amanzio et al., 2011; Palermo et al., 2014, 2015), for which
ACC functionality is central (Braver et al., 2001; Nee et al.,
2007).
As far as we know, no previous studies have evaluated
DRSA using an event-related functional MRI (fMRI) paradigm
based on response-inhibition. Since the ACC network plays
an important role in response-inhibition competence (Braver
et al., 2001; Nee et al., 2007), and in our previous study
patients who were unaware of their deficits exhibit impaired
performance in response-inhibition tasks (Amanzio et al., 2011;
Palermo et al., 2014, 2015), we predicted a relationship between
DRSA in PD and cingulate hypofunctionality. Considering
the above, the two main purposes of the study were: (1)
to evaluate possible association between DRSA and response-
inhibition performance and (2) to explore and describe the
neural substrate of DRSA during a response-inhibition task in PD
patients.
MATERIALS AND METHODS
Participants
We prospectively screened 30 patients between January 2016 and
November 2017 from the Parkinson’s and Movement Disorders
Unit of the University of Turin, Italy. Selection was made among
patients evaluated for possible access to advanced therapy in
terms of deep brain stimulation intervention.
A good clinical response to levodopa with the presence of
peak-of-dose dyskinesias and wearing off or on-off phenomena
was the first required selection criteria (Amanzio et al., 2010,
2014; Palermo et al., 2017). Subjects took part in the study only
if:
(i) they did not have a random on-off
(ii) did not have early-morning and painful dystonia
(iii) they did not show behavioural abnormalities such as major
depression, dysthymia or alexithymia based on DSM-V
criteria (American Psychiatric Association [APA], 2013)
(iv) they did not have past and present neurological disorder
and/or brain organic conditions (other than PD)
(v) they were not taking drug therapies that could directly
impact cognitive functioning, other than dopaminergic
pharmacological replacement treatment;
(vi) they had more than secondary school education
(vii) they had a Mini Mental State Examination (MMSE)
(Folstein et al., 1975) score≥27, in order to include only
cognitively non-impaired subjects (Amanzio et al., 2010,
2014; Palermo et al., 2017).
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Procedures
Neurological evaluation was performed both in the absence of
drug therapy and over the course of the maximum-benefit-peak
of the first daily dose (Amanzio et al., 2010, 2014; Palermo et al.,
2017). As regards the off-state, patients were assessed at least
10 h after therapeutic withdrawal, while in the on-state they
were assessed within 2 h of the pharmacological assumption.
DRSA assessment and the neuropsychological evaluation were
performed in the on-state and took at least an hour and a half
for each patient.
Importantly, all patients were in therapeutic washout during
neuroimaging acquisition, to avoid possible confounding effects
of dopamine treatment effects on response-inhibition execution
and subsequent fMRI results (Robertson et al., 2015). Indeed, last
pharmacological administration was performed in all patients 8 h
before the experimental session.
Neurological Evaluation and DRSA
Assessment
The neurological evaluation was performed using the Unified PD
Rating Scale revised by the Movement Disorders Society (MDS-
UPDRS) (Antonini et al., 2013), which was administered by
neurologists blind to the aim of the study. In particular, the motor
assessment was performed on the basis of Section III; dyskinesias
were assessed using Section IV. Disease stage was rated using the
Modified Hoehn and Yahr Scale (Hoehn and Yahr, 1967).
The Dyskinesia rating Scale (DS) (Amanzio et al., 2010,
2014; Palermo et al., 2017) was used to measure awareness
of movement disorders. It is a 4-point scale for which the
severity of dyskinesias is evaluated separately by the patient
and the examiner, while the first performs some selected tasks.
Score ranges from 0 (total absence of dyskinesias) to 3 (severe
dyskinesias). A Dyskinesias Index (DS-I) was calculated by
subtracting the patient’s judgments from those of the examiner.
Higher scores indicated worse error detection in performance
monitoring and so more severe DRSA.
Neuropsychological and
Neuropsychiatric Assessment
The neuropsychological assessment was based on the guidelines
by the Task Force commissioned by the Movement Disorders
Society to identify Mild Cognitive Decline (Litvan et al., 2012;
Goldman et al., 2013). As in our previous studies (Amanzio et al.,
2014; Palermo et al., 2017), the test battery included the MMSE to
detect the presence of a general cognitive deterioration; attention,
perceptual tracking of a sequence and speeded performance were
analysed using the Trail Making Test part A (TMT-A); executive
functions using the TMT-B and TMT B-A, and the Wisconsin
Card Sorting test (WCST); memory abilities with subscales IV
and VII of the Wechsler Memory Scale (WMS). Lastly, the ability
to access the verbal lexicon was evaluated using the Phonemic
Fluency Test – letters F, A, S (FAS) (Amanzio et al., 2014; Palermo
et al., 2017).
Neuropsychiatric assessment consisted of the Beck Anxiety
Inventory (BAI), the Beck Depression Inventory (BDI), the
Apathy Scale (AS), the Young Mania Rating Scale (YMRS) and
the Brief Psychiatric Rating Scale 4.0 (BPRS 4.0) (Amanzio et al.,
2014; Palermo et al., 2017).
Scanning Procedure, Activation
Paradigm, fMRI Data Preprocessing and
Analyses
Neuroimaging data acquisition was performed on a 3T
Philips Ingenia scanner (Neuroscience Institute of Turin –
Neuroimaging Centre). Images of the whole brain were acquired
using a T1-weighted sequence (TR = 4.8 ms, TI = 1650 ms,
TE = 331 ms, voxel-size = 1 mm× 1 mm× 1 mm).
During acquisition, the subject was asked to perform a
response inhibition ACC-sensitive task (GO-NoGO paradigm),
in which the subject had to respond to frequent “GO” stimuli
inhibiting the response to infrequent “NoGO” stimuli (the letter
“X” with a frequency of 17%), (Braver et al., 2001; Amanzio
et al., 2011; Palermo et al., 2014, 2015). Every stimulus was shown
for 250 ms with a 1000 ms inter-stimulus interval. The two
stimulus types (X and non-X) were presented in random order
in a continuous series of 232 trials (Amanzio et al., 2011; Palermo
et al., 2014, 2015). Subjects had to respond by pressing a button
with their right thumb. The paradigm we used is a prototypical
task to measure the ability to inhibit an overpowering response
(Braver et al., 2001).
Functional data were acquired using T2∗-weighted EPI
(TR = 2.20 s, TE = 35 ms, slice-matrix = 64 × 64, slice
gap = 0.28 mm, FOV = 24 cm, flip angle = 90◦, slices aligned on
the AC-PC line).
Image data preprocessing was performed using SPM8, while
group-statistics results were visualised using MRIcron. All
functional images were spatially realigned to the first volume and
anatomical images were co-registered to the mean of them. The
functional images were normalised to the Montreal Neurological
Institute (MNI), space and smoothed with a 8 mm full-width
half-maximum (FWHM), Gaussian Kernel. In order to remove
low-frequency drifts, high-pass temporal filtering with a cut-off
of 128 s was applied.
After preprocessing, we applied a General Linear Model
(GLM) (Friston et al., 2007) to convolve the “GO” and
“NoGO” stimuli with canonical hemodynamic response function
(HRF). The GLM consisted of two categorical regressors (“GO”
and “NoGO” as paradigm conditions), and seven parametric
regressors of no interest: six motion regressors in order to
correct residual effects of head motion and one (the levodopa
equivalent daily dose, LEDD) to exclude any potential influence
of pharmacological therapy on fMRI results. At the second level,
neural correlates of response-inhibition function were explored
by performing a one-sample t-test of the contrast “NoGO” vs.
“GO” across all the participants. Results were corrected for
multiple comparison by small volume correction [SVC], with a
sphere of 10 mm radius centred on ACC (our primary region
of interest), according to the coordinates reported in the meta-
analysis by Need, Wager and Jonides (Nee et al., 2007). Finally, in
order to identify which brain regions were associated with DRSA
and how task-related activation during response inhibition and
DS-I scores were reciprocally correlated, we performed a linear
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regression of individual scores on DS-I onto whole-brain results
for the contrast “NoGO” vs. “GO” (pFWE < 0.05, at cluster level).
Data from the neuropsychological evaluation are listed in
Table 2. The neuropsychiatric evaluation showed normative
values in both the evaluation phases, on and off. Furthermore,
the neuropsychological assessment performed in the on-phase
reported normal cognitive profiles.
Statistical Analysis
Statistical analyses were performed using SPSS version 21.0 (IBM
Corp, 2013), for Windows. Data for clinical characteristics and
neuropsychological assessment of the subjects are expressed as
the mean± standard deviation.
As far as the “GO-NoGO” paradigm is concerned, patients’
behavioural performance were evaluated in terms of percentage
of correct answers (percentage of GO to which the subject
responded); percentage of wrong answers (percentage of NoGO
to which the subject responded); reaction times (milliseconds
from the appearance of the stimulus to the pressure of the
response button).
Correlations between DS-I scores and response-inhibition
performance were examined using Spearman’s rank-order
correlations. A p-value of<0.05 was considered statistically
significant.
RESULTS
Of thirty subjects screened, three patients withdrew from
the study, while twenty-seven patients (eight women, 19
men), with idiopathic PD, receiving levodopa treatment
and presenting motor fluctuations, were enrolled. Disease
duration was 10.98 ± 0.94 (mean ± SD) years. The
pharmacological treatment had been ongoing for about 8
years and consisted of levodopa associated with dopamine
agonists (LEDD = 982.86± 92.41). Dyskinesias appeared about 3
years before the neuropsychological evaluation. Patients reported
normal cognitive profiles at the first level of cognitive profile
assessment. Data for key clinical variables are summarised in
Table 1. More information regarding the experimental sample
can be found on Supplementary Tables I–III.
Parkinson’s Disease (PD), patient successfully performed the
attentive task (GO) in 84% of cases (correct target), while they
properly inhibited the incorrect answer in 64% of cases.
By normal standards, the association between DS-I scores
and performance on the GO condition would not be considered
statistically significant (r = −0.177; p = 0.377). Importantly,
DS-I scores strongly correlated with percent errors on the
NoGO condition (r = 0.491, p = 0.009). Indeed, the worse
the response-inhibition’s performance the worse the ability of a
subject to notice and adequately assess the severity of his/her own
dyskinesias.
In the “NoGO” vs. “GO” fMRI contrast, expected activation
was found in a functional cluster including the bilateral ACC
and part of the pre-Supplementary Motor Area (pre-SMA), as
shown in Figure 1. Linear correlations between neural response
during response-inhibition and DRSA scores (as expressed by
DS-I) are summarised in Table 3 and depicted in Figures 2, 3.
DS-I scores negatively correlated with the NoGO/GO response
in the bilateral ACC, bilateral anterior insular cortex (AIC) and
right dorsolateral prefrontal cortex (DLPFC) (pFWE < 0.05) (see
Table 4).
DISCUSSION
We studied twenty-seven PD patients to better elucidate the
link between brain dysfunction and concomitant cognitive-
behavioural disturbances (McGlynn and Schacter, 1989; Lezak
TABLE 1 | Demographic values and motor assessment.
Neurological assessment On-phase (mean ± SD) Off-phase (mean ± SD)
Age mean ± SD 64.81 ± 1.31
Education (years) mean ± SD 9.46 ± 0.98
Gender (male/female) 19/8
years since the first symptoms appeared median [Q1;Q3] 10 [8;13]
years since the diagnosis was made median [Q1;Q3] 9.5 [6.75;13]
years since the dyskinesia appeared median [Q1;Q3] 3 [1;5]
hours of Daily off median [Q1;Q3] 2 [0.75;4]
hours of Daily on median [Q1;Q3] 12 [6.75;14]
L-dopa (years of treatment) mean ± SD 8.46 ± 0.84
LEDD (mg) mean ± SD 982.86 ± 92.41
MDS-UPDRS total score [200] 52.37 ± 4.33 76.59 ± 5.63
Part I [52] 9.50 ± 1.56 10.65 ± 1.63
Part II [52] 10.92 ± 1.20 15.74 ± 1.39
Part III [72] 23.10 ± 2.75 40.91 ± 3.39
Part IV [24] 10.23 ± 1.02 7.67 ± 0.67
Hoehn and Yahr scale [5] 2.12 ± 0.16 2.44 ± 0.12
Maximum scores for the neurological examination are shown in square brackets. mg, milligrammes; H&Y, Hoehn and Yahr scale; SD, Standard Deviation; Q1, first quartile;
Q3, third quartile; N, frequency; MDS-UPDRS, Movement Disorder Society –Unified Parkinson Disease Rating Scale.
Frontiers in Psychology | www.frontiersin.org 4 September 2018 | Volume 9 | Article 1765
fpsyg-09-01765 September 18, 2018 Time: 16:50 # 5
Palermo et al. Neural Substrate of Dyskinesias-Reduced-Self-Awareness
TABLE 2 | Neuropsychiatric and neuropsychological assessment in the on-phase of the disease.
Median Range Mean ± Std. Deviation Cut -off
Neuropsychiatric assessment
AS [42] 6 2–30 8.28 ± 1.20 ≤14
BDI [39] 6 2–21 7.92 ± 1.01 ≤10
BAI [63] 12 3–23 12.56 ± 1.28 ≤21
YMRS [44] 1 0–21 3-08 ± 1.01 ≤12
BPRS 4.0 [168] 38 24–54 37.52 ± 1.59
Neuropsychological assessment
MMSE [30] 28 27–30 28 ± 19 ± 0.22 ≥24
TMT A [500] 48 30–159 59.04 ± 5.36 ≤94
TMT B [500] 176.5 70–500 227.23 ± 29.64 ≤283
TMT B-A 112.5 29–432 165.35 ± 26.06 ≤187
FAS 30 14–50 29.04 ± 1.96 ≥17.35
Wechsler Memory Scale 4 7 1.5–19 7.61 ± 0.80
Wechsler Memory Scale 7 13.5 7–21.5 14.13 ± 0.78
WCST % 53.12 14–78.13 48.13 ± 3.55 ≥37.1
WCST % errors 46.88 21.87–86 52.23 ± 3.54
WCST % perseverative errors 37.5 14.70–57.14 38.31 ± 2.23 ≤42.7
Reponse Inhibition task: Go
Percent Targets 83,72
Reaction Time 174.68 61.34–396,24 175.66 ± 15.88
Reponse Inhibition task: NoGo
Percent errors 36.28
Reaction Time 151.05 69.60–398.32 169.30 ± 17.68
Awareness for Levodopa-induced diskinesias is also shown. Where possible, the maximum scores for each test are shown in square brackets. Wherever there is a
normative value, the cut-off scores are given in the statistical normal direction; the values refer to the normative data for healthy controls matched according to age and
education. Cells in grey indicate the absence of a normative cut-off. N, frequency; AS, Apathy Scale; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; YMRS,
Young Mania Rating Scale; BPRS 4.0, Brief Psychiatric Rating Scale version 4.0; MMSE, Mini-Mental state Examination; TMT, Trail Making Test; FAS, Verbal Fluency;
WCST, Wisconsin Card Sorting Test; GAM, Global Awareness of Movement Disorders; DS-I, Dyskinesias Subtracted-Index.
FIGURE 1 | FMRI results from the “NoGO” vs. “GO” contrast.
et al., 2004; Amanzio et al., 2011; Palermo et al., 2014; Maier et al.,
2016), such as DRSA. First, we confirmed the specific and central
role of the ACC in the response-inhibition function. Then, we
identified a novel negative correlation between DS-I scores and
fMRI responses from the NoGO/GO contrast, suggesting that,
in our sample, DRSA was specifically associated with reduced
functional recruitment of cingulo-frontal (bilateral ACC – R
DLPFC), and cingulo-opercular (bilateral ACC – bilateral AIC)
regions during the employed response-inhibition task. These
findings cannot be merely attributed to cognitive impairment,
since all PD patients obtained scores above cut-off on the overall
neuropsychological test battery.
It has been reported that DRSA «is characterised by a failure
to acknowledge a particular neuropsychological deficit relative to
specific functions, i.e., in the case in question, “action”» (Amanzio
et al., 2014; Palermo et al., 2017). The phenomenon has attracted
growing interest in recent years (Jenkinson et al., 2009; Amanzio
et al., 2010, 2014; Maier et al., 2012, 2016; Pietracupa et al., 2013;
Palermo et al., 2017). In previous studies approximately half of
PD patients exhibited DRSA to some extent (Amanzio et al.,
2010; Maier et al., 2012; Pietracupa et al., 2013). In particular,
our own studies observed reduced awareness of dyskinesias in
44% (Amanzio et al., 2010), and 53% (Amanzio et al., 2014),
of enrolled subjects. Moreover, in the study by Sitek et al., 43%
of patients rated their dyskinesias as less severe than did their
caregivers (Sitek et al., 2011). More recently, DRSA was reported
in 61% and in 23% of PD patients. (Maier et al., 2012, 2016;
Pietracupa et al., 2013).
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TABLE 3 | DRSA assessment as measured by the DS-I scale.
Patient code Patient rate Clinician rate DS-I
1 0 3 3
2 2 2 0
3 0 3 3
4 1 2 1
5 1 2 1
6 1 1 0
7 1 2 1
8 2 3 1
9 1 2 1
10 1 2 1
11 0 3 3
12 1 1 0
13 1 1 0
14 1 2 1
15 1 1 0
16 2 2 0
17 1 2 1
18 1 2 1
19 2 3 1
20 1 2 1
21 1 3 2
22 0 3 3
23 0 3 3
24 0 3 3
25 1 3 2
26 0 3 3
27 0 3 3
We have demonstrated elsewhere (Amanzio et al., 2010,
2014; Palermo et al., 2017), a significant association between
DRSA and reduced functional recruitment of the cingulo-frontal
and cingulo-opercular pathways due to prolonged iatrogenic
overstimulation and have also already discussed (Amanzio
et al., 2010, 2014), possible grounds of inconsistency between
our observations and those of others who did not find such
an association using neuropsychological approaches (Jenkinson
et al., 2009; Maier et al., 2012; Pietracupa et al., 2013; Amanzio
et al., 2014). The limitations of these studies, which obtained
negative results, had been previously reported (Amanzio et al.,
2010, 2014).
This study suggests a possible evidence that chronic
dopaminergic overstimulation of mesocorticolimbic circuitries –
prolonged over the years – might be considered one of
the mechanisms responsible for DRSA pathogenesis. Another
possible intervening factor might also go “beyond” chronic
dopaminergic overstimulation and affect the mesocorticolimbic
circuitries on their own, as we should have ruled out potential
confounding effects of replacing pharmacotherapy on our fMRI
results: fMRI sequences were acquired in therapeutic washout),
and, moreover, LEDD was included as a covariate of no interest
(i.e., nuisance regressor), in all individual first level fMRI analyses
(in order to control for any residual effect due to “chronic”
influence of therapy).
FIGURE 2 | Brain area negatively associated with DS-I scores in the “NoGO”
vs. “GO” contrast.
In the case of fMRI contrasts, we only focused on the response-
inhibition function as specifically elicited by the “NoGO” vs.
“GO” condition and applied regional correction, considering
significant results only within the ACC. This was done in order
to evaluate, in our sample, the degree of significance in the
expected cluster of activation. Against, regression analysis was
not restricted to the sole ACC in an effort to not constrain our
interpretations to one brain region highly likely to be involved
in DRSA pathogenesis. We have here confirmed that ACC is not
only significantly active in the contrast NoGO vs. GO, but it is
also the area that – among all the areas emerged from the linear
regression analysis – expresses the main negative correlation peak
with the DS-I scale. We can therefore suggest that ACC could be
considered the main hub to interpret DRSA, with the DLPFC and
the insula holding the role of supporting actors.
Interestingly, the relationship we found between DRSA
and reduced functional recruitment of the cingulo-frontal
and cingulo-opercular pathways refers to regions engaged in
loading executive-monitoring onto the processing of task-
relevant information, so as to avoid interference by goal-
irrelevant stimuli. In particular, the DLPFC is a principal region
of the “cognitive-executive” network (CEN), while the ACC and
AIC have been identified as major nodes of the “salience” network
(SN). These macroscale networks are typically recognised as
topographically and functionally distinct from the “default mode”
network, which on the contrary subserves inwardly oriented
(i.e., self-referential), processing during both wakeful rest and
task-execution conditions (Fox et al., 2005; Dosenbach et al.,
2007). These areas have to be considered as “hubs” of a wider
cognitive control network, globally known as “task positive” (as
opposed to the default mode, also called “task negative” network),
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FIGURE 3 | Strength of the fMRI responses (percent change of the BOLD signals) in NoGO trials.
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TABLE 4 | Linear correlation between the “NoGO” vs. “GO” contrast and DS-I scores (FWE p < 0.05).
MNI Coordinates r-score p-value
X Y Z
Brain areas (cluster’s extent in number of voxels)
rACC (982) 4 26 29 −0.84 0.000
lACC (798) −5 25 27 −0.81 0.000
rAIC (1855) 33 22 -4 −0.64 0.001
lAIC (1654) −39 27 3 −0.41 0.002
rDLPFC (2128) −45 10 47 −0.39 0.007
Peak activity coordinates are given in MNI space. Peak activities are significant at p < 0.05, FWE corrected for multiple comparisons at the voxel level. ACC, anterior
cingulate cortex; AIC, anterior insular cortex; DLPFC, dorsolateral prefrontal cortex; r, right; l, left.
that includes and connects different functional systems involved
in response-inhibition, working memory, action monitoring,
representation of the affective qualities of interoceptive signals
and sensory events.
The ACC plays important roles in each of these functions
(Dosenbach et al., 2006, 2007). Indeed, action monitoring
is particularly important in situations that require higher
processing capacity. In this case, ACC is concerned with
conflict monitoring in several contexts. This includes the online
monitoring of responses allowing the identification of errors,
as per earlier error-detection theories, and also the detection
of conflict between different possible responses to a stimulus,
event, or situation. Considering the above, ACC is believed
to be involved in attentional processes, particularly “attention
for action” (Posner et al., 1988). Most recently, the conflict-
monitoring model has been further revised in an effort to
consider the findings related to a seeming role for ACC in
decision making (Botvinick, 2007). Interestingly the joint action
of ACC and AIC can provide an eye-opening perspective on the
functions of these regions, as they appear to constitute input
(AIC) and output (ACC) hubs of a system based on “awareness of
self.” This system may be regarded as an “integrated awareness”
of physical, affective and cognitive states, generated by the
integrative functions of the AIC and then re-represented in
ACC, having the purpose of providing elements for the selection
of, and preparation for, responses to inner or outer events.
Our finding of a tight relationship between limited functional
recruitment of the cingulo-frontal and cingulo-opercular regions
and DRSA suggests that reduction in self-awareness of LID in
PD could be interpreted as a specific impairment of an executive
function related to metacognitive awareness (i.e., attention-for-
action/target selection, motor response selection inhibition and
error detection in performance monitoring), in line with our
previous results obtained with a neuropsychological approach
(Amanzio et al., 2010, 2014; Palermo et al., 2017).
LIMITATIONS SECTION
The present study has been carefully designed and reached its
aims; however, some critical aspects have to be outlined. First,
there is no current consensus about standard tools for DRSA
assessment, so opting for a scale in place of another could
represent a confounding factor. However, DRSA is still detected
using different instruments and none of them has been able
to prevail as superior to the others. Second, our analyses had
been conducted on a relatively small sample, which might reduce
statistical power to detect effects and limit generalisation of
results. However, our study has to be considered as an exploratory
attempt to investigate possible neural underpinnings of DRSA,
using an effective and specific ACC-sensitive fMRI paradigm in
a selected patient population. Indeed, our sample was clinically
homogeneous in terms of disease duration, disease severity,
and pharmacological treatment. Moreover, our patients did not
present cognitive impairment or behavioural alterations that
could compromise the DRSA assessment or the interpretation of
the main results.
CONCLUSION
This study of DRSA and its neural correlates has relevant
clinical implications as this disorder is involved in diagnostic,
nosological and prognostic factors that directly affect treatment
adherence. Unawareness is often related to poor clinical
outcomes and impaired psycho-social functioning. Unaware
patients increase caregivers’ burden as they are unable to track
changes in their cognitive and behavioural status, thus requiring
additional assistance. We believe that theoretical models of
unawareness have greater clinical utility and are more effective
if they integrate fMRI and neuropsychological data, given the
relevance of detecting possible psycho-biological markers of this
phenomenon in PD. Importantly, to the best of our knowledge,
this is the first study to investigate the relationship between
response-inhibition disabilities and DRSA, in cognitively intact
patients with PD, using a specific executive (ACC-sensitive) task
during an event related fMRI session.
FUTURE PERSPECTIVES
It would be useful to consider the execution of specific response-
inhibition task along with the neurological evaluation and
neuropsychological assessment in order to define “tailored”
interventions in DRSA and adopt a personalised clinical
approach avoiding increased doses of dopaminergic drugs, which
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would in turn enhance the risk of side effects. On the other hand,
we have here shown that DRSA pathogenesis in PD may also be
considered as “intrinsic” and not necessarily related to chronic
dopaminergic overstimulation. Therefore, future studies will be
helpful in order to further characterise DRSA features in PD,
replicating our findings in a larger group of patients both in the
on- and off-phase of daily replacing therapy.
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